Expertise in
5
conditions

Anton Y. Peleg

99 Commercial Road, 
Melbourne, VIC, AU 
Expertise in
5
conditions
99 Commercial Road, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Anton Peleg practices in Melbourne, Australia. Mr. Peleg is highly rated in 5 conditions, according to our data. His top areas of expertise are Pseudomonas Stutzeri Infections, Urinary Tract Infection (UTI), Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, and Lung Transplant.

His clinical research consists of co-authoring 205 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

99 Commercial Road, Melbourne, VIC 3004, Australia
Other Locations
Building 76, Wellington Road, Melbourne, VIC 3800, Australia
Wellington Rd, Clayton, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Stepped-wedge Cluster Randomised Controlled Trial to Increase Antibiotic Appropriateness in Residential Aged Care Facilities: a Nurse-led Bundled Antimicrobial Stewardship Intervention.
Stepped-wedge Cluster Randomised Controlled Trial to Increase Antibiotic Appropriateness in Residential Aged Care Facilities: a Nurse-led Bundled Antimicrobial Stewardship Intervention.
Enrollment Status: Unknown
Publish Date: January 13, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol
Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol
Enrollment Status: Completed
Publish Date: June 14, 2018
Randomized Controlled Trial of Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Due to Ceftriaxone Non-susceptible E. Coli and Klebsiella Species.
Randomized Controlled Trial of Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Due to Ceftriaxone Non-susceptible E. Coli and Klebsiella Species.
Enrollment Status: Terminated
Publish Date: November 27, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

205 Total Publications

Publisher Correction: Rational design of a hospital-specific phage cocktail to treat Enterobacter cloacae complex infections.
Publisher Correction: Rational design of a hospital-specific phage cocktail to treat Enterobacter cloacae complex infections.
Journal: Nature microbiology
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Peleg's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile